SAMSUNG BIOLOGICS CO.,LTD. Logo

SAMSUNG BIOLOGICS CO.,LTD.

A CDMO providing end-to-end development and manufacturing services for the biopharma industry.

207940 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도바이오대로 300, 인천광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) providing end-to-end services to the global biopharmaceutical industry. The company offers a comprehensive service suite from late discovery, cell line and process development to large-scale, CGMP-compliant manufacturing of drug substance (DS) and drug product (DP). Its offerings also include analytical testing services and development support for new modalities such as antibody-drug conjugates (ADCs) and mRNA. Leveraging advanced infrastructure and a strong regulatory track record, Samsung Biologics supports its clients, which include many of the world's leading pharmaceutical companies, from clinical development through to commercial supply.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SAMSUNG BIOLOGICS CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-11 00:00
Registration Form
[기재정정]증권신고서(분할)
Korean 4.7 MB
2025-09-09 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 8.2 KB
2025-09-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-09-05 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 16.8 KB
2025-09-02 00:00
Registration Form
[기재정정]증권신고서(분할)
Korean 5.2 MB

Automate Your Workflow. Get a real-time feed of all SAMSUNG BIOLOGICS CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SAMSUNG BIOLOGICS CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Dottikon ES Holding AG Logo
Exclusive synthesis of APIs & fine chemicals via hazardous reactions for pharma/biotech industries.
Switzerland DESN
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea 176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea 180400
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea 044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan 4549

Talk to a Data Expert

Have a question? We'll get back to you promptly.